Floatz logo

34 assets in CD4+/CD56+ Hematodermic Neoplasm

Therapeutic assets addressing CD4+/CD56+ Hematodermic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tagraxofusp
CD4+/CD56+ Hematodermic Neoplasm
French Innovative Leukemia OrganisationP2BB (70)
Cyclophosphamide
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2BB (66)
Fludarabine
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2BB (65)
Cytarabine
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2B (60)
Dexasone
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2B (60)
Rituximab
CD4+/CD56+ Hematodermic Neoplasm
St. Jude Children's Research HospitalP2B (60)
Venetoclax
CD4+/CD56+ Hematodermic Neoplasm
French Innovative Leukemia OrganisationP2B (60)
(+)-Vincristine
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2B (60)
Methotrexate
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2B (59)
Busulfanum
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2B (57)
Tacrolimus
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2B (57)
Thiotepa
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2B (57)
Adriamycin
CD4+/CD56+ Hematodermic Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Cyclosporin A
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2CCC (53)
Mercaptopurine Anhydrous
CD4+/CD56+ Hematodermic Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Prednisone
CD4+/CD56+ Hematodermic Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
cd123-car-nk cells
CD4+/CD56+ Hematodermic Neoplasm
Chongqing Precision Biotech Co., LtdP1/2CCC (48)
Imgn632
CD4+/CD56+ Hematodermic Neoplasm
AbbVieP1/2CC (47)
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes
CD4+/CD56+ Hematodermic Neoplasm
City of Hope Medical CenterP1CC (43)
Anti-Cd123 Car Nk Cells
CD4+/CD56+ Hematodermic Neoplasm
Chongqing Precision Biotech Co., LtdP1CC (43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
CD4+/CD56+ Hematodermic Neoplasm
City of Hope Medical CenterP1CC (43)
Azacitidine
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (43)
CD123-CAR T
CD4+/CD56+ Hematodermic Neoplasm
St. Jude Children's Research HospitalP1CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP1CC (43)
Hydrocortisone
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (43)
Mesna
CD4+/CD56+ Hematodermic Neoplasm
St. Jude Children's Research HospitalP1CC (43)
mgd024
CD4+/CD56+ Hematodermic Neoplasm
MacroGenicsP1CC (43)
Orca-T
CD4+/CD56+ Hematodermic Neoplasm
Orca Biosystems, Inc.P1CC (43)
q702
CD4+/CD56+ Hematodermic Neoplasm
Mayo ClinicP1CC (43)
Autologous Car123 T Lymphocytes
CD4+/CD56+ Hematodermic Neoplasm
Institute of Hematology and Blood Transfusion, Czech RepublicEarly P1C (39)
Tagraxofusp-Erzs
CD4+/CD56+ Hematodermic Neoplasm
M.D. Anderson Cancer CenterP2C (36)
sar443579
CD4+/CD56+ Hematodermic Neoplasm
SanofiP1/2NR ()